VIDEO: ‘Critical to test’ for HBV, latent TB coinfection to reduce liver injury

In a Healio video exclusive, Harvey Kaufman, MD, senior medical director at Quest Diagnostics, highlighted the need for concurrent hepatitis B and latent tuberculosis testing to mitigate the risk for drug-induced liver injury.“The next step is health care providers who have patients with either of these two conditions should test for the other, given this large overlap and due to the availability of therapies that will mitigate the risk to the liver,” Kaufman, co-author of a recent study that assessed the prevalence of HBV and latent TB coinfection, said. “There are someRead More

Related Articles

2019 Telehealth Bill

In 2019, Florida passed the Telehealth Bill which establishes standards of practice for telehealth services, including patient evaluations, record-keeping, and controlled substances prescribing. The bill…